Keedy, Vicki L.
Lenz, Heinz-Josef
Saltz, Leonard
Whisenant, Jennifer G.
Berlin, Jordan D.
Camacho, Luis H.
Funding for this research was provided by:
Merck
Article History
Received: 16 November 2017
Accepted: 16 January 2018
First Online: 29 January 2018
Compliance with ethical standards
:
: VLK is a consultant for Karyopharm and Janssen, and has research funding from Lilly, Plexxicon, CytRx, Daiichi, Threshold, Janssen, Roch, Axtrazeneca, MedPacto, Immune Design, and GSK. HJL has served as consultant for Genentech, Bayer, BMS, Merck KG, Boehringer Ingelheim, Taiho, Symphogen and has clinical trial support from Taiho, Genentech, Incyte, Abbvie, Novartis, Bayer, BMS, Merck, EMD and Boehringer Ingelheim. LS has research funding from Taiho. JB has served as a consultant for Celgene, Genentech, Aduro, Boston Biomedical, Janssen, Cornerstone, Symphogen, and Bayer and has institutional research funding from Genentech, Abbvie, Taiho, Bayer, 5Prime, Phoenix, Incyte, and Vertex. LHC receives research funds from MacroGenics Inc., and serves on the vaccine advisory committee for Merck, Inc. For the remaining author, none were declared.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained for all individual participants included in the study.